Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NEU-411 by Neuron23 for Parkinson's Disease: Likelihood of Approval
NEU-411 is under clinical development by Neuron23 and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...